Stock comparison
Merck & Co., Inc. is 56.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($308.78 B vs $5.47 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
MRK is larger
Merck & Co., Inc. is 56.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($308.78 B vs $5.47 B).
Market value leader
MRK
Merck & Co., Inc. is 56.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($308.78 B vs $5.47 B).
Revenue leader
MRK
DNTH: $2.04M vs MRK: $65.01B.
Profit leader
MRK
DNTH: -$162.34M vs MRK: $18.25B.
Margin leader
MRK
DNTH: -7973.3% vs MRK: 28.1% net margin.
| Metric | DNTH | MRK |
|---|---|---|
| Market cap | $5.47 B | $308.78 B |
| US-listed rank | #1352 | #45 |
| Revenue (latest FY) | $2.04M | $65.01B |
| Net income (latest FY) | -$162.34M | $18.25B |
| Net margin | -7973.3% | 28.1% |
| P/E (trailing FY) | - | 16.9x |
| SEC filings | 624 | 998 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
Merck & Co., Inc. is 56.5x more valuable than Dianthus Therapeutics, Inc. /DE/ by market capitalization ($308.78 B vs $5.47 B).
In their latest fiscal years, Dianthus Therapeutics, Inc. /DE/ reported $2.04M in revenue while Merck & Co., Inc. reported $65.01B.
Full pages: Dianthus Therapeutics, Inc. /DE/ and Merck & Co., Inc., or browse the full rankings.